Enzolytics Inc (ENZC)

[falon]

Some select Lonza historic achievements:


1897

Foundation of Lonza AG Electricity Works in Gampel, Valais (Switzerland), on the banks of river Lonza. The electricity was used to manufacture calcium carbide and acetylene.

2010

Lonza signs agreement with GlaxoSmithKline (GSK) to secure capacity and expertise in biological manufacturing to support ongoing development of GSK’s biopharmaceuticals portfolio. Thereby, Lonza will supply manufacturing capacity for five early-stage monoclonal antibodies.
https://www.gsk.com/en-gb/media/press-releases/gsk-signs-agreement-with-lonza-to-secure-capacity-and-expertise-in-biological-manufacturing-to-support-ongoing-development-of-gsk-s-biopharmaceuticals-portfolio/

2011

Lonza expands its viral-based therapeutics business with the construction of a new, state-of-the-art cGMP clean room located adjacent to its existing Houston, TX (USA) operations.

2014

Bristol-Myers Squibb and Lonza expand manufacturing agreement. The contract expansion will include the production of commercial quantities of a second Bristol-Myers Squibb biologic medicine at Lonza’s mammalian manufacturing facility in Portsmouth, NH (USA).


Lonza signs exclusive agreement with Index Ventures for the development and manufacture of biologics for portfolio companies.

Lonza extends partnership with Pharmacyclics to support manufacturing of recently approved oncology therapeutic, IMBRUVICA™.

2015

Lonza signs a long-term manufacturing supply agreement with Alexion, under which Lonza will construct and launch a new suite dedicated to Alexion in Portsmouth, NH (USA).


2018

Lonza opens world’s largest dedicated cell- and gene- therapy manufacturing facility in Houston, TX (USA).

2020

Lonza entered into a landmark ten-year collaboration agreement with Moderna Inc. to manufacture the drug substance for Moderna’s COVID-19 Vaccine, alongside other mRNA-based collaboration projects from Moderna’s innovation pipeline.

Lonza announced an agreement to manufacture AstraZeneca's COVID-19 long-acting antibody combination.
https://www.fiercepharma.com/manufacturing/astrazeneca-taps-lonza-to-churn-out-drug-substance-for-covid-19-antibody
2021

Lonza was recognized by Ethisphere® as one of the world's most ethical companies in 2021.


Enzolytics and Lonza Bioscience Combine Technologies to Fast-track Development and Production of Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibodies produced by Enzolytics

https://www.lonza.com/company-overview/our-history


Many many questions about Lonza and ENZC relationship.

Most probably won''t be answered due to confidentiality however some must be due to disclosure requirements.

Here are my thoughts on our relationship with Lonza:

Lonza undeniably understands what ENZC is trying to accomplish.
They understand the science, the technology and the methodology.

Lonza have the tools and facilities to gets us where we want to go(FDA IND) with proven success.

Lonza signs many types of agreements and if things do well they are inclined to extend them.